Agenus Inc (AGEN)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
2.89 -0.16 (-5.25%) 04/30/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 2.85 -0.04 (-1.38%) 18:14 ET
for Wed, Apr 30th, 2025
Results
download Want to compare other data? Select Fields| Symbol | AGEN | JSPR | TIL | ||
| Company | Agenus Inc | Jasper Therapeutics Inc. | Instil Bio Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.06 | 5.05 | 11.37 | ||
| High | 3.08 | 5.67 | 13.52 | ||
| Low | 2.85 | 5.00 | 10.80 | ||
| Last | 2.89 | 5.49 | 12.85 | ||
| Change | -0.16 | +0.34 | +1.13 | ||
| % Change | -5.25% | +6.60% | +9.64% | ||
| Volume | 543,200 | 195,900 | 298,700 | ||
| 20-Day Average Volume | 810,640 | 175,210 | 174,255 | ||
| Previous Close | 3.05 | 5.15 | 11.72 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 2.16 | 4.27 | 15.39 | ||
| 20-Day Raw Stochastic | 74.75% | 92.91% | 15.07% | ||
| 20-Day Relative Strength | 60.93% | 55.28% | 42.07% | ||
| Weighted Alpha | -55.59 | -55.36 | -81.43 | ||
| Today's Opinion | 40% Sell | 56% Sell | 100% Sell | ||
| Previous Opinion | 40% Sell | 56% Sell | 100% Sell | ||
| Last Month's Opinion | 100% Sell | 100% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.40% since 04/23/25 | +20.39% since 04/23/25 | -37.38% since 04/23/25 | ||
| Low | 2.63 on 04/28/25 | 4.50 on 04/24/25 | 10.80 on 04/30/25 | ||
| High | 3.19 on 04/29/25 | 5.67 on 04/30/25 | 20.99 on 04/24/25 | ||
| 1-Month | |||||
| %Chg | +80.63% since 03/28/25 | +23.09% since 03/28/25 | -28.93% since 03/28/25 | ||
| Low | 1.38 on 04/07/25 | 3.13 on 04/09/25 | 10.80 on 04/30/25 | ||
| High | 3.40 on 04/23/25 | 5.67 on 04/30/25 | 24.40 on 04/23/25 | ||
| 3-Month | |||||
| %Chg | -18.36% since 01/30/25 | -18.06% since 01/30/25 | -46.48% since 01/30/25 | ||
| Low | 1.38 on 04/07/25 | 3.13 on 04/09/25 | 10.80 on 04/30/25 | ||
| High | 4.10 on 01/31/25 | 7.06 on 02/06/25 | 25.80 on 02/19/25 | ||
| 6-Month | |||||
| %Chg | -34.17% since 10/30/24 | -74.77% since 10/30/24 | -62.51% since 10/30/24 | ||
| Low | 1.38 on 04/07/25 | 3.13 on 04/09/25 | 10.80 on 04/30/25 | ||
| High | 4.45 on 10/31/24 | 26.05 on 12/03/24 | 37.24 on 11/13/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 77,192 | 77,363 | 76,870 | ||
| Shares Outstanding, K | 25,309 | 15,022 | 6,559 | ||
| Annual Sales | 103,460,000 | 0 | 0 | ||
| Annual Net Income | -227,210,000 | -71,270,000 | -74,140,000 | ||
| Last Quarter Sales | 26,840,000 | 0 | 0 | ||
| Last Quarter Net Income | -45,860,000 | -24,320,000 | -11,900,000 | ||
| 60-Month Beta | 1.58 | 2.55 | 1.75 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -2.04 on 03/11/25 | -1.62 on 02/27/25 | -1.82 on 03/04/25 | ||
| Latest Earnings Date | 05/06/25 | 05/13/25 | 05/09/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||